Anthony Bernard Schryvers

This inventor holds 30 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Transferrin Receptor Research. Top assignees: Connaught Laboratories Limited, Aventis Pasteur Limited, Engineered Antigens Inc.. Active years: 1992-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony Bernard Schryvers. Retrieved from https://idiyas.com/inventor/anthony-bernard-schryvers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 30 (Patent Applications = 3)

% Patents Active = 93.3

CIPO Patents = 1 (Patent Applications = 10)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 199(Granted Patents)

Company Filing History:

11 out of 145

Connaught Laboratories Limited

patents

7 out of 75

Aventis Pasteur Limited

patents

4 out of 4

Engineered Antigens Inc.

patents

4. 2 out of 213

University of Saskatchewan

patents

5. 2 out of 113

University Technologies International, Inc.

patents

6. 1 out of 16

Pasteur Merieux Serums Et Vaccins

patents

7. 1 out of 1

The Board of Governors of the University

9. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...

Areas of Expertise:

Transferrin Receptor

Immunogenic Compositions

Vaccines

Polynucleotides

Polypeptides

Haemophilus

Lactoferrin

Bacterial Immunity

Recombinant Proteins

Cloning

Surface Receptor Proteins

Nucleic Acids

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12296000 - SLAM polynucleotides and polypeptides and uses thereof (2025-05-13),

2. 11872275 - SLAM polynucleotides and polypeptides and uses thereof (2024-01-16),

3. 11123418 - SLAM polynucleotides and polypeptides and uses thereof (2021-09-21),

4. 10149900 - Immunogenic compositions and vaccines derived from bacterial surface receptor proteins (2018-12-11),

5. 7241449 - [object Object] (2007-07-10),

6. 7118749 - Transferrin receptor genes (2006-10-10),

7. 6887686 - Cloning and expression of Haemophilus somnus transferrin-binding proteins (2005-05-03),

8. 6610506 - Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same (2003-08-26),

9. 6440701 - Transferrin receptor genes of Moraxella (2002-08-27),

10. 6437096 - Transferrin receptor of moraxella (2002-08-20),

11. 6391316 - Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use (2002-05-21),

12. 6361779 - Transferrin receptor genes (2002-03-26),

13. 6358727 - Haemophilus transferrin receptor genes (2002-03-19),

14. 6348198 - Lactoferrin receptor protein (2002-02-19),

15. 6344200 - Lactoferrin receptor protein (2002-02-05),

Title: The Inventor Anthony Bernard Schryvers

Introduction: Anthony Bernard Schryvers is a renowned inventor based in Calgary, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Anthony Bernard Schryvers holds several patents in the areas of technology and engineering, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Anthony Bernard Schryvers has demonstrated a keen interest in developing cutting-edge solutions to complex challenges, earning him a reputation as a forward-thinker in the industry.

Collaborations: Anthony Bernard Schryvers has collaborated with leading companies and research institutions to bring his inventions to life, fostering a culture of innovation and creativity in the process.

Conclusion: In conclusion, Anthony Bernard Schryvers continues to inspire with his inventive spirit and dedication to pushing the boundaries of what is possible in the world of technology and beyond.

Profile summary based on public USPTO records.